| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
February 6, 2024
BREA, CALIFÓRNIA, 6 de fevereiro — A Beckman Coulter Diagnostics, uma das líderes mundiais em diagnóstico clínico, anunciou hoje a nomeação de Kevin O’Reilly como novo presidente,...
-
February 6, 2024
BREA, CALIFORNIA, 6 febbraio - Beckman Coulter Diagnostics, leader nella diagnostica clinica, ha annunciato oggi la nomina di Kevin O’Reilly a nuovo presidente, che succederà a Julie Sawyer...
-
February 6, 2024
BREA, CALIFORNIE, 6 février — Beckman Coulter Diagnostics, leader dans le domaine du diagnostic clinique, a annoncé aujourd’hui la nomination de Kevin O’Reilly au poste de président,...
-
February 6, 2024
BREA, CALIFORNIA, 6 de febrero de 2024 — Beckman Coulter Diagnostics, empresa líder en diagnóstico clínico, ha anunciado hoy el nombramiento de Kevin O'Reilly como nuevo presidente,...
February 6, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and...
-
February 6, 2024
BREA, KALIFORNIEN, 6. Februar – Beckman Coulter Diagnostics, ein führendes Unternehmen der klinischen Diagnostik, gab heute die Ernennung von Kevin O’Reilly zum neuen Präsident des...
-
January 30, 2024
O novo analisador complementa os laboratórios centrais ao contribuir para o desenvolvimento das capacidades dos laboratórios satélite e de laboratórios hospitalares independentes DUBAI, 30 DE...
-
January 30, 2024
Il nuovo analizzatore completa l’offerta dei laboratori hub migliorando le capacità dei loro laboratori satellite e quelle degli ospedali indipendenti DUBAI, 30 GENNAIO 2024 - Beckman Coulter...
-
January 30, 2024
Le nouvel analyseur complète les plateaux techniques centraux en améliorant les capacités des laboratoires périphériques et des structures hospitalières indépendantes DUBAÏ, 30 JANVIER...
-
January 30, 2024
El nuevo analizador complementa los laboratorios centrales mejorando las capacidades de los laboratorios de hospitales satélite y públicos independientes DUBÁI, 30 DE ENERO DE 2024 — Beckman...
-
January 30, 2024
Das neue Analysensystem ergänzt Zentrallabore durch die Verbesserung der Leistungsfähigkeit von Satellitenlabors sowie von unabhängigen kommunalen Krankenhäusern DUBAI, 30. JANUAR 2024 – Beckman
January 29, 2024New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs DUBAI , UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...
July 25, 2023Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed,...
July 25, 2023Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical...
July 19, 2023Connecting the DxH 900 Workcell and DxH Slidemaker Stainer II with the Scopio X100HT High-throughput Digital Cell Morphology Platform Improves Lab Efficiency by Automating Hematology Workflow By...
July 17, 2023Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter's High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay...
-
May 15, 2023
O analisador de imunoensaio DxI 9000 Access apresenta o maior rendimento por área ocupada da indústria: até 215 testes/hora/metro quadrado As inovações reforçam o desempenho do ensaio e a...
-
May 15, 2023
L’analizzatore per dosaggi immunometrici Access DxI 9000 vanta la più alta produttività del settore per ingombro: fino a 215 test/ora/metro quadrato Le innovazioni apportate rafforzano le...
-
May 15, 2023
L’analyseur d’immunodosage DxI 9000 Access offre une des capacités de traitement les plus élevées du marché par rapport à son encombrement : jusqu’à 215 tests/heure/mètre carré Ses...
-
May 15, 2023
El analizador de inmunoensayo DxI 9000 Access cuenta con el rendimiento por tamaño más alto de la industria: hasta 215 pruebas/hora/metro cuadrado Las innovaciones refuerzan el rendimiento del...
-
May 15, 2023
Das DxI 9000 Access-Immunassay-Analysensystem bietet den branchenweit höchsten Durchsatz pro Standfläche: Bis zu 215 Tests/Stunde/Quadratmeter Innovationen optimieren Assayleistung und...
May 15, 2023DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with...
-
January 31, 2023
Collaboration to Add MeMed BV to Beckman Coulter Test Menu for use on Access Family of Immunoassay Analyzers BREA, Calif. and HAIFA, Israel , Jan. 31, 2023 /PRNewswire/ -- Beckman Coulter...
-
October 11, 2022
StoCastic's TriageGo, a triage decision support tool that integrates electronic health records and emergency department workflows, will be a cornerstone of Beckman Coulter's Clinical Decision...
July 25, 2022Beckman Coulter, global leader in advanced diagnostics, today announced that it will partner with Massachusetts General Hospital to validate the use of the novel Monocyte Distribution Width (MDW)...
